Immune Mediated Degeneration and Possible Protection in Glaucoma
The underlying pathomechanisms for glaucoma, one of the most common causes of blindness worldwide, are still not identified. In addition to increased intraocular pressure (IOP), oxidative stress, excitotoxicity, and immunological processes seem to play a role. Several pharmacological or molecular/ge...
Main Authors: | Teresa Tsai, Sabrina Reinehr, Ana M. Maliha, Stephanie C. Joachim |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-09-01
|
Series: | Frontiers in Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fnins.2019.00931/full |
Similar Items
-
Intravitreal Therapy Against the Complement Factor C5 Prevents Retinal Degeneration in an Experimental Autoimmune Glaucoma Model
by: Sabrina Reinehr, et al.
Published: (2019-12-01) -
Antibody and Protein Profiles in Glaucoma: Screening of Biomarkers and Identification of Signaling Pathways
by: Nadine Auler, et al.
Published: (2021-12-01) -
In a novel autoimmune and high-pressure glaucoma model a complex immune response is induced
by: Sabrina Reinehr, et al.
Published: (2024-03-01) -
Glaucoma Animal Models beyond Chronic IOP Increase
by: Teresa Tsai, et al.
Published: (2024-01-01) -
The Role of Complement Dysregulation in Glaucoma
by: Cindy Hoppe, et al.
Published: (2024-02-01)